US FDA approves Novartis drug to treat kidney disease
The US Food and Drug Administration has approved the use of a Novartis drug to reduce excess protein in the urine of patients with a type of kidney disease. The drug Fabhalta is already approved to treat adults with paroxysmal nocturnal haemoglobinuria, a rare blood disorder.
ENTRADAS POPULARES
UK sets new climate target for 2035
noviembre 13, 2024
Children go back to school after Valencia floods
noviembre 13, 2024
Researchers document huge decline in African elephants
noviembre 13, 2024
Mission: Impossible 8 title revealed
noviembre 13, 2024
TRANSMISIÓN EN VIVO